Abstract:HIV infection continues to spread throughout the world without any end insight, and is still the fastest increasing cause of mortality. The majority of HIV-infected patients have HIV-associated oral mucosal lesions at different stages of the disease. In many patients, oral lesions could be the first sign of their HIV infection. Therefore, knowledge of HIV infection has become a critically important requirement for professionals responsible for oral health care delivery and early detection of HIV infection. Oral candidiasis (OC), hairy leukoplakia (HL), and Kaposi sarcoma (KS) are the most common oral lesions strongly associated with HIV infection. Both pseudomembranous and erythematous OC occur in over 95% of HIV-infected patients throughout the oral cavity, highly related to a reversed CD4/CD8 cell ratio. Attached gingiva would be a unique site of OC, only occurring in HIV-infected patients. Because of decreased gastric acid secretion in most HIV-infected patients, fluconazole, the antifungal drug that can be absorbed easily despite the gastric pH change, would be the best choice for systemic antifungal treatment. HL primarily occurs in HIV-infected male patients on the lateral border of the tongue. However, similar-appearing changes can also occur in HIV-negative persons. HL is not related to precancerous leukoplakia or dysplasia. Our latest study indicated that the infection of Epstein-Barr virus (EBV) might not be the definitive criteria for the diagnosis of HL and that the reciprocal activation of EBV and HIV within the epithelium may be the critical event in the development of HL. Our study demonstrated that CD4-bearing oral mucosal Langerhans cells (LC) could be the target of HIV infection, the effector to alter LC number and its antigen processing capability, as well as the vector to pass the virus to submucosal memory T cells, which would be responsible for the second pathway of HIV transmission through mucosal contact with HIV. HIV-associated depletion of LC would lead to impairment of the oral mucosal surveillant system, resulting in opportunistic oral mucosal lesions, such as OC and HL. KS has been the most common tumor associated with HIV infection and has been one of the AIDS defining diseases. The latest study indicated that this tumor is related to opportunistic infection of human herpes simplex virus 8. Because of its reactive type nature clinically and histologically, KS has now been considered a pseudomalignancy. Intralesional injection of cytotoxic drugs has been effective in treatment. Since HIV-infected patients have demonstrated a higher propensity for developing allergic and adverse reactions to antibiotics, bleeding tendency and slow wound healing after dental surgery, decreased levels of neutrophil counts, and xerostomia, a modified dental therapy would be essential for management of HIV-infected dental patients. In addition, concerns about HIV transmission from patient to dentist, dentist to patient, and between patients should be clarified.

Hiv Diagnosis Due To Kaposi ́S Sarcoma Lesion In The Oral Cavity: Case Report.

Kaposi’s Sarcoma Manifested As Lower Gastrointestinal Bleeding in a HIV/HBV-co-infected Liver Cirrhosis Patient: A Case Report

Multiple Oral Kaposi ́S Sarcomas Associated With Acquired Immunodeficiency Syndrome - Case Report.

[Immune Activation in AIDS Related Kaposi's Sarcoma].

Disseminated Kaposi Sarcoma: Case Report.

Gastrointestinal Kaposi Sarcoma without Dermatological Lesions: A Case Report

Endoscopic Appearance of Oropharyngeal and Upper GI Kaposi's Sarcoma in an Immunocompromised Patient

Complications of Untreated Advanced HIV/AIDS With Kaposi Sarcoma in a Young African American Male: A Case Report

Pulmonary Kaposi Sarcoma in the Era of Antiretroviral Therapy: A Case Series

Kaposi's sarcoma and its associated herpesvirus

Kaposi Sarcoma in an HIV-Negative Patient

Sign of Leser-Trélat Associated with Kaposi Sar-coma in an Immunocompetent Man

The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma.

Vascular Conjunctival Lesion in a Patient With a Recent Diagnosis of HIV Infection

Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report

Kaposi sarcoma and vertebral involvement in people with HIV: a case report and systematic literature review

[Clinical and research advances in oral AIDS]

Skin nodules in a young patient with HIV/AIDS

Kaposi Sarcoma after Kidney Transplantation: a Case Report and Literature Review

Iatrogenic Kaposi’s Sarcoma in an HIV-Negative Young Male With Crohn’s Disease and IgA Nephropathy: A Case Report and Brief Review of the Literature

Fatal pulmonary Kaposi sarcoma in an HIV seronegative AIDS patient